Historical Valuation
Kewaunee Scientific Corp (KEQU) is now in the Fair zone, suggesting that its current forward PE ratio of 17.36 is considered Fairly compared with the five-year average of 12.59. The fair price of Kewaunee Scientific Corp (KEQU) is between 18.08 to 42.69 according to relative valuation methord.
Relative Value
Fair Zone
18.08-42.69
Current Price：37.50
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Kewaunee Scientific Corp (KEQU) has a current Price-to-Book (P/B) ratio of 1.54. Compared to its 3-year average P/B ratio of 1.89 , the current P/B ratio is approximately -18.62% higher. Relative to its 5-year average P/B ratio of 1.57, the current P/B ratio is about -2.04% higher. Kewaunee Scientific Corp (KEQU) has a Forward Free Cash Flow (FCF) yield of approximately 4.76%. Compared to its 3-year average FCF yield of 2.05%, the current FCF yield is approximately 132.11% lower. Relative to its 5-year average FCF yield of -2.57% , the current FCF yield is about -285.62% lower.
P/B
Median3y
1.89
Median5y
1.57
FCF Yield
Median3y
2.05
Median5y
-2.57
Competitors Valuation Multiple
AI Analysis for KEQU
The average P/S ratio for KEQU competitors is 0.74, providing a benchmark for relative valuation. Kewaunee Scientific Corp Corp (KEQU.O) exhibits a P/S ratio of 0.68, which is -8.46% above the industry average. Given its robust revenue growth of 46.75%, this premium appears sustainable.
Performance Decomposition
AI Analysis for KEQU
1Y
3Y
5Y
Market capitalization of KEQU increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of KEQU in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is KEQU currently overvalued or undervalued?
Kewaunee Scientific Corp (KEQU) is now in the Fair zone, suggesting that its current forward PE ratio of 17.36 is considered Fairly compared with the five-year average of 12.59. The fair price of Kewaunee Scientific Corp (KEQU) is between 18.08 to 42.69 according to relative valuation methord.
What is Kewaunee Scientific Corp (KEQU) fair value?
KEQU's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Kewaunee Scientific Corp (KEQU) is between 18.08 to 42.69 according to relative valuation methord.
How does KEQU's valuation metrics compare to the industry average?
The average P/S ratio for KEQU's competitors is 0.74, providing a benchmark for relative valuation. Kewaunee Scientific Corp Corp (KEQU) exhibits a P/S ratio of 0.68, which is -8.46% above the industry average. Given its robust revenue growth of 46.75%, this premium appears sustainable.
What is the current P/B ratio for Kewaunee Scientific Corp (KEQU) as of Jan 10 2026?
As of Jan 10 2026, Kewaunee Scientific Corp (KEQU) has a P/B ratio of 1.54. This indicates that the market values KEQU at 1.54 times its book value.
What is the current FCF Yield for Kewaunee Scientific Corp (KEQU) as of Jan 10 2026?
As of Jan 10 2026, Kewaunee Scientific Corp (KEQU) has a FCF Yield of 4.76%. This means that for every dollar of Kewaunee Scientific Corp’s market capitalization, the company generates 4.76 cents in free cash flow.
What is the current Forward P/E ratio for Kewaunee Scientific Corp (KEQU) as of Jan 10 2026?
As of Jan 10 2026, Kewaunee Scientific Corp (KEQU) has a Forward P/E ratio of 17.36. This means the market is willing to pay $17.36 for every dollar of Kewaunee Scientific Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Kewaunee Scientific Corp (KEQU) as of Jan 10 2026?
As of Jan 10 2026, Kewaunee Scientific Corp (KEQU) has a Forward P/S ratio of 0.68. This means the market is valuing KEQU at $0.68 for every dollar of expected revenue over the next 12 months.